GLP‐1 receptor agonists in Alzheimer's disease and MCI: a meta‐analysis
Abstract INTRODUCTION Alzheimer's disease (AD) is the leading cause of dementia in older individuals and remains a major clinical and socioeconomic burden. Despite the success of anti‐amyloid therapies in reducing biomarker burden, more effective and safer treatments are still needed. Given the emerging evidence of a r...